T. Rowe Price Associates’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$89.4M Buy
2,474,025
+107,505
+5% +$4.5M 0.01% 636
2025
Q4
$111M Buy
2,366,520
+2,289,269
+2,963% +$96.7M 0.01% 606
2025
Q3
$2.51M Buy
77,251
+3,168
+4% +$113K ﹤0.01% 1637
2025
Q2
$3.05M Buy
74,083
+1,492
+2% +$57.6K ﹤0.01% 1472
2025
Q1
$3.03M Sell
72,591
-476,899
-87% -$24.8M ﹤0.01% 1427
2024
Q4
$32.2M Buy
549,490
+19,844
+4% +$1.17M ﹤0.01% 873
2024
Q3
$36.6M Sell
529,646
-244,658
-32% -$15.8M ﹤0.01% 838
2024
Q2
$49.4M Sell
774,304
-287,320
-27% -$21.6M 0.01% 730
2024
Q1
$99.7M Sell
1,061,624
-311,924
-23% -$25.1M 0.01% 549
2023
Q4
$101M Sell
1,373,548
-355,844
-21% -$22.8M 0.01% 542
2023
Q3
$108M Sell
1,729,392
-316,923
-15% -$21.3M 0.02% 502
2023
Q2
$151M Sell
2,046,315
-637,454
-24% -$48.6M 0.02% 441
2023
Q1
$212M Sell
2,683,769
-380,632
-12% -$27.5M 0.03% 370
2022
Q4
$209M Sell
3,064,401
-43,584
-1% -$2.77M 0.03% 368
2022
Q3
$165M Sell
3,107,985
-16,366,764
-84% -$978M 0.03% 397
2022
Q2
$1.22B Sell
19,474,749
-1,172,961
-6% -$71.9M 0.15% 135
2022
Q1
$1.33B Sell
20,647,710
-206,917
-1% -$14.1M 0.13% 154
2021
Q4
$1.75B Sell
20,854,627
-3,102,256
-13% -$249M 0.16% 131
2021
Q3
$1.87B Sell
23,956,883
-926,592
-4% -$77M 0.18% 118
2021
Q2
$1.89B Sell
24,883,475
-174,570
-0.7% -$12.2M 0.18% 126
2021
Q1
$1.61B Sell
25,058,045
-392,098
-2% -$23.6M 0.16% 135
2020
Q4
$1.38B Buy
25,450,143
+481,947
+2% +$23.1M 0.14% 154
2020
Q3
$992M Buy
24,968,196
+355,471
+1% +$14.8M 0.11% 189
2020
Q2
$1B Sell
24,612,725
-2,572,522
-9% -$101M 0.13% 171
2020
Q1
$975M Sell
27,185,247
-994,432
-4% -$46.1M 0.15% 141
2019
Q4
$1.44B Sell
28,179,679
-1,432,741
-5% -$68.2M 0.19% 118
2019
Q3
$1.3B Sell
29,612,420
-78,765
-0.3% -$3.53M 0.18% 125
2019
Q2
$1.48B Buy
29,691,185
+180,171
+0.6% +$7.59M 0.21% 117
2019
Q1
$1.13B Buy
29,511,014
+67,514
+0.2% +$2.44M 0.17% 141
2018
Q4
$877M Buy
29,443,500
+1,157,257
+4% +$36.5M 0.15% 144
2018
Q3
$946M Sell
28,286,243
-33,845
-0.1% -$1.11M 0.14% 162
2018
Q2
$822M Sell
28,320,088
-24,777
-0.1% -$753K 0.13% 171
2018
Q1
$848M Sell
28,344,865
-73,714
-0.3% -$2.39M 0.13% 174
2017
Q4
$975M Sell
28,418,579
-83,602
-0.3% -$2.74M 0.16% 145
2017
Q3
$848M Sell
28,502,181
-277,072
-1% -$7.98M 0.14% 157
2017
Q2
$830M Sell
28,779,253
-49,225
-0.2% -$1.27M 0.15% 159
2017
Q1
$673M Sell
28,828,478
-24,469
-0.1% -$575K 0.13% 189
2016
Q4
$611M Sell
28,852,947
-127,220
-0.4% -$2.78M 0.12% 199
2016
Q3
$656M Buy
28,980,167
+661,337
+2% +$15.2M 0.13% 182
2016
Q2
$644M Buy
28,318,830
+20,885
+0.1% +$558K 0.14% 175
2016
Q1
$792M Buy
28,297,945
+225,357
+0.8% +$5.62M 0.17% 149
2015
Q4
$681M Buy
28,072,588
+656,643
+2% +$13.6M 0.14% 168
2015
Q3
$450M Buy
27,415,945
+12,225
+0% +$238K 0.1% 224
2015
Q2
$559M Buy
27,403,720
+1,089,480
+4% +$22M 0.12% 201
2015
Q1
$486M Buy
26,314,240
+209,430
+0.8% +$3.97M 0.1% 240
2014
Q4
$512M Buy
26,104,810
+2,659,400
+11% +$51.2M 0.11% 221
2014
Q3
$434M Buy
23,445,410
+223,420
+1% +$4.78M 0.09% 248
2014
Q2
$564M Buy
23,221,990
+1,804,340
+8% +$39.2M 0.12% 204
2014
Q1
$488M Buy
21,417,650
+352,470
+2% +$7.69M 0.11% 225
2013
Q4
$416M Buy
21,065,180
+580,180
+3% +$11.4M 0.1% 254
2013
Q3
$423M Buy
20,485,000
+864,920
+4% +$16.5M 0.11% 236
2013
Q2
$317M Buy
+19,620,080
New +$339M 0.08% 289

Other funds holding BRKR

T. Rowe Price Associates's BRKR Position: Q1 2026 in Review

T. Rowe Price Associates increased its Bruker (BRKR) stake by 4.5% in Q1 2026, buying an estimated $4.5M and bringing the position to 2,474,025 shares worth $89.4M. The position accounts for 0.01% of the portfolio, ranked #636.

T. Rowe Price Associates first reported a position in BRKR in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.89B in Q2 2021. 343 funds tracked by Wall St. Rank hold BRKR as of Q1 2026.

  • T. Rowe Price Associates held 2,474,025 shares of Bruker worth $89.4M as of Q1 2026.
  • T. Rowe Price Associates bought 107,505 Bruker shares in Q1 2026, an estimated $4.5M.
  • Bruker made up 0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #636 holding.
  • T. Rowe Price Associates first reported a position in Bruker in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Bruker position peaked at $1.89B in Q2 2021.
  • 343 funds tracked by Wall St. Rank held Bruker as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.